GE Healthcare Discovery IGS 730 - Manual (Page 9)

About GE Healthcare
GE Healthcare provides transformational medical technologies
and services that are shaping a new age of patient care.
Our broad expertise in medical imaging and information
technologies, medical diagnostics, patient monitoring
systems, drug discovery, biopharmaceutical manufacturing
technologies, performance improvement and performance
solutions services help our customers to deliver better care to
more people around the world
at a lower cost. In addition, we partner with healthcare
leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable
healthcare systems.
Our “healthymagination” vision for the future invites the
world to join us on our journey as we continuously develop
innovations focused on educing costs, increasing access and
improving quality around the world. Headquartered in the
United Kingdom, GE Healthcare is a unit of General Electric
Company (NYSE: GE). Worldwide, GE Healthcare employees
are committed to serving healthcare professionals and their
patients in more than 100 countries. For more information
about GE Healthcare, visit our website at www.gehealthcare.
com.
GE Healthcare
Chalfont St.Giles,
Buckinghamshire,
UK
Data subject to change.
Marketing Communications GE Medical Systems
Société en Commandite Simple au capital de 65.146.245 Euros
283 rue de la Minière – 78533 Buc Cedex France RCS Versailles B 315 013 359
A General Electric company, doing business as GE Healthcare
GE and GE Monogram are trademarks of General Electric Company.
* Trademarks of General Electric Company.
** Edwards Sapien is a trademark of Edwards Lifesiences Corporation.
Discovery IGS 730 with the Large Display Monitor and Dose Dicom SR cannot be marketed
(including advertising and promotions) in Belarus, Bosnia, Canada, China, Croatia, Japan,
Kazakhstan, Nigeria, Russia, Saudi Arabia, Serbia, Slovenia, Thailand, Ukraine and United Arab
Emirates.
This equipment has not been pre-marketing registration approved yet and the shipment and
the effective marketing can only occur when the registration is approved for the following
countries: Argentina, Brazil, Colombia, Costa Rica, Mexico, Panama, Peru, Uruguay, Venezuela.
Refer to your Sales representative.
1 Increased SOD (SOD = 82 cm) in Discovery IGS 730 enables a 10 to 15% of air kerma
reduction at the interventional reference point compared to a system with an SOD of 72 cm,
with detector dose maintained at the same beam quality (kVp and spectral filter).
In clinical use, the results of the application of dose reduction techniques will vary depending
on the clinical task, patient size, anatomical location and clinical practice. The Interventional
radiologist, assisted by a physicist as necessary has to determine the appropriate settings for
each specific clinical task.
2 35m² rooms can accommodate a maximum of 2 back-out. Space left for additional
equipment may be limited.
3 According to simulations performed with a surgical monitors suspension using the open
monitor suspension option.
4 Option may not be available in all countries, check with your local representative
HCSDGSP
AMC03133DOC1278054r
ev1
GE Healthcare
@GEHealthcare
GE Healthcare
GE Healthcare
Scan to visit our website
gehealthcare.com/igs730
GE Healthcare, Europe
Headquarters Buc, France
+33 800 90 87 19
GE Healthcare, Middle East and Africa
Istanbul, Turkey
+ 90 212 36 62 900
GE Healthcare, North America
Milwaukee, USA
+ 1 866 281 7545
GE Healthcare, Latin America
Sao Paulo, Brazil
+ 55 800 122 345
GE Healthcare, Asia Pacific
Tokyo, Japan
+ 81 42 585 5111
GE Healthcare, ASEAN
Singapore
+65 6291 8528
GE Healthcare, China
Beijing, China
+ 86 800 810 8188
GE Healthcare, India
Bangalore, India
+91 800 209 9003